EUVIMEDEUVIMED entdecken
Crossref

Endometrial Transcriptome Changes following Short-Term Liraglutide Treatment in Infertile Women with Polycystic Ovarian Syndrome and Obesity

Vesna Salamun, Luca Lovrecic, Ales Maver, Borut Peterlin, Helena Ban Frangez, Gaetano Riemma, Antonio Simone Laganà, Rok Herman, Andrej Janez, Eda Vrtacnik Bokal, Mojca Jensterle

Gynecologic and Obstetric Investigation · 2025

DOI: 10.1159/000547513 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, 2025. Verfasst von Vesna Salamun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Obstetrics and Gynecology, Department of Human Reproduction, University Medical Centre Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Liraglutide, Polycystic Ovary Syndrome, Endometrium, Infertility, Female. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of the study was to evaluate whether the use of a 12-week liraglutide treatment changes the endometrial gene expression during the implantation window in infertile obese women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF).

Design

A cross-sectional study involving treated and non-treated subjects was conducted.

Participants

Infertile women with PCOS and BMI ≥30 kg/m2 participated in the study.

Setting

The study was conducted at a tertiary-care university hospital.

Methods

Endometrial biopsies were collected from 20 infertile women during the implantation window, 1 month prior to entering the IVF procedure. Endometrium transcriptome of 10 participants, who had been pretreated with low-dose liraglutide 1.2 mg QD for 12 weeks and achieved at least a 5% reduction in body weight, was compared to endometrium transcriptome of 10 treatment-naive participants, who had a stable body weight over the last 12 weeks. Next-generation sequencing was conducted to analyze RNA from the samples. The resulting data were processed to discern key canonical pathways and predict activations or inhibitions. Gene networks were constructed based on established published associations.

Results

Gene Set Analysis (GSA) identified a total of 17 canonical pathways that were significantly differentially expressed between the two groups. The most important canonical pathways included GLP-1 receptor activation, modulation of inflammation and oxidative stress response, alterations in glucose homeostasis, and energy consumption, with YWHAG being a notable central gene in the associated network. The results indicate a possible involvement of the AKT pathway in the liraglutide mode of action.

Limitations

The main limitations include its cross-sectional design and considerable number of upregulated and downregulated genes.

Conclusions

Short-term low-dose liraglutide treatment prior to IVF was associated with changes in the endometrial transcriptome that could potentially be important for improving endometrial receptivity and fertility in women with obesity and PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutidePolycystic Ovary SyndromeEndometriumInfertility, FemaleObesityTranscriptomeHypoglycemic AgentsHumansFemaleAdultCross-Sectional StudiesFertilization in VitroEmbryo Implantation

Stichwörter der Autor:innen

Endometrial gene expressionIn vitro fertilizationLiraglutide treatmentObesityPolycystic ovarian syndromeTranscriptomic analysis

Substanzen

LiraglutideHypoglycemic Agents

Autor:innen und Institutionen

  • Division of Obstetrics and Gynecology, Department of Human Reproduction, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Clinical Institute of Medical Genetics, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Obstetrics and Gynecology Unit, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Unit of Obstetrics and Gynecology, "Paolo Giaccone" Hospital, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
  • Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Zitieren

APA

Salamun, V., Lovrecic, L., Maver, A., Peterlin, B., Ban Frangez, H., Riemma, G., Laganà, A. S., Herman, R., Janez, A., Vrtacnik Bokal, E., & Jensterle, M. (2025). Endometrial Transcriptome Changes following Short-Term Liraglutide Treatment in Infertile Women with Polycystic Ovarian Syndrome and Obesity. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000547513

Vancouver

Salamun V, Lovrecic L, Maver A, Peterlin B, Ban Frangez H, Riemma G, et al. Endometrial Transcriptome Changes following Short-Term Liraglutide Treatment in Infertile Women with Polycystic Ovarian Syndrome and Obesity. Gynecologic and Obstetric Investigation. 2025. doi:10.1159/000547513

BibTeX
@article{Salamun2025,
  author = {Salamun, Vesna and Lovrecic, Luca and Maver, Ales and Peterlin, Borut and Ban Frangez, Helena and Riemma, Gaetano and Laganà, Antonio Simone and Herman, Rok and Janez, Andrej and Vrtacnik Bokal, Eda and Jensterle, Mojca},
  title = {Endometrial Transcriptome Changes following Short-Term Liraglutide Treatment in Infertile Women with Polycystic Ovarian Syndrome and Obesity},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2025},
  doi = {10.1159/000547513}
}
Kostenlos starten →